Effectiveness of a Web-based Prevention Program for Postpartum Depression

Official Title: “Using the Internet for English/Spanish Randomized Trials for Postpartum Depression”

The original trial will evaluate the effectiveness of a Web-based program in preventing postpartum depression. The site has been modified to provide materials from both conditions.

Depression is a mental health condition in which symptoms such as sadness, inability to feel pleasure, and loss of energy interfere with a person's normal life. Postpartum depression is a type of depression experienced by women after giving birth to a child. In this study an intervention for preventing postpartum depression that has been adapted for use over the Internet will be tested. Administering a depression-prevention program over the Internet has several advantages: after the initial investment is made to develop the program, costs are lower for treating each patient; online treatment is more accessible to a greater number of people than any given clinic; and participants who may be worried about a stigma associated with mental health problems often feel more comfortable seeking information through the Internet. Previous research has shown that symptoms of depression can be reduced through Internet-based interventions, but no research has examined such interventions specifically for postpartum depression. The program tested in this study is not aimed at replacing in-person mental health care—in fact, people who have signs of serious depression will be directed to in-person mental health care. Instead, the program is aimed at providing an additional mental health service among the range of available options.

The original trial was a two-arm pilot prevention of postpartum depression trial comparing the Internet-based course called "Mothers and Babies/Mamás y Bebés" (M&B) to informational materials on postpartum depression. In the original trial, 1088 pregnant women were recruited and randomized (as anticipated) to either condition. The study Website has therefore been modified such that all participants who consent to participate will now receive materials from both conditions. We have eliminated the randomization procedure.

As in the original study, participants be allowed to enroll at any time during their pregnancies and will be followed for 6 months after the birth of their children, so the length of participation will vary between 6 and 15 months. After undergoing a screening process, participants will now have access to both the Internet-based course called "Mothers and Babies/Mamás y Bebés" (M&B) and the informational materials. The informational materials will include information about postpartum depression and depression that may occur before childbirth. All participants will be invited via email to complete monthly assessments for the duration of the study. These assessments will measure mood, depression, and satisfaction with the assigned intervention.

Intervention(s) in this Clinical Trial

• Behavioral: Mothers and babies Internet course and PPD informational brochure
  • An eight-lesson, self-help, Web-based program for the prevention of postpartum depression based on cognitive behavioral therapy, social-learning, and attachment theory. The PPD informational brochure is a four-page pamphlet that contains information about postpartum depression.

Arms, Groups and Cohorts in this Clinical Trial

• Experimental: Self-help course and information

Primary Measures

• Edinburgh Postnatal Depression Scale (EPDS)
  • Time Frame: Measured monthly for 6 months postpartum
    Safety Issue?: Yes

Secondary Measures

• Center for Epidemiologic Studies-Depression (CES-D) Scale
  • Time Frame: Measured monthly for 6 months postpartum
    Safety Issue?: Yes

Inclusion Criteria:

• Pregnant
• Fluent in English or Spanish

Gender Eligibility for this Clinical Trial: Female

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 60 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers

Lead Investigator: University of California, San Francisco Other

Overall Clinical Trial Officials and Contacts

Alinne Z. Barrera, PhD Principal Investigator University of California, San Francisco  

Overall Contact: Alinne Z. Barrera, PhD 650-433-3854 alinne.barrera@ucsf.edu

Information obtained from ClinicalTrials.gov on February 09, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00816725

Study ID Number: F32 MH077371

ClinicalTrials.gov Identifier: NCT00816725

Health Authority: United States: Federal Government

English-speaking participants click here for more information on this study.

Spanish-speaking participants click here for more information on this study.